RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF WEEKLY ADMINISTRATION OF DARBEPOETIN ALFA IN ANEMIC PATIENTS WITH LUNG OR GYNECOLOGIC CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY

被引：0
|
作者：
Katsumata, N. [1 ]
Fujiwara, Y. [1 ]
Katakami, N. [2 ]
Nishiwaki, Y. [3 ]
Tsuboi, M. [4 ]
Takeda, K. [5 ]
Nakanishi, T. [6 ]
Ichinose, Y. [7 ]
Kawahara, Y. [8 ]
Hotta, T. [6 ]
Saijo, N. [9 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan
[3] Natl Canc Ctr Hosp E, Chiba, Japan
[4] Tokyo Med Univ Hosp, Tokyo, Japan
[5] Osaka City Gen Hosp, Osaka, Japan
[6] Nagoya Med Ctr, Natl Hosp Org, Aichi, Japan
[7] Kyushu Canc Ctr, Natl Hosp Org, Fukuoka, Japan
[8] Chuo Chest Med Ctr, Natl Hosp Org Kinki, Osaka, Japan
[9] Kinki Univ, Sch Med, Osaka 589, Japan
来源：
VOX SANGUINIS | 2009年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [31] Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 μg every 2 weeks) in anemic patients with cancer receiving chemotherapy
    Waltzman, R
    Croot, C
    Justice, GR
    Fesen, MR
    Charu, V
    Williams, D
    ONCOLOGIST, 2005, 10 (08): : 642 - 650
  • [32] Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)
    Cheng, Ying
    Wu, Lin
    Huang, Dingzhi
    Wang, QiMing
    Fan, Yun
    Zhang, XiQin
    Fan, HuiJie
    Yao, WenXiu
    Liu, BaoGang
    Yu, GuoHua
    Pan, YueYin
    Xu, Fei
    He, ZhiYong
    Dong, XiaoRong
    Ma, Rui
    Min, XuHong
    Ge, XiaoSong
    Chen, Hualin
    Liu, Qun
    Hu, YanPing
    Liu, Ying
    Yang, Chen
    Yang, Yang
    Li, Xiucui
    Zhou, Li
    LUNG CANCER, 2024, 188
  • [33] Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)
    Tjan-Heijnen, VCG
    Caleo, S
    Postmus, PE
    Ardizzoni, A
    Burghouts, JTM
    Buccholz, E
    Biesma, B
    Gorlia, T
    Crott, R
    Giaccone, G
    Debruyne, C
    Manegold, C
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 248 - 257
  • [34] A double-blind, placebo-controlled study of once-weekly epoetin alfa in children with cancer undergoing myelosuppressive chemotherapy.
    Razzouk, BI
    Hockenberry, M
    Hinds, PS
    Rackoff, W
    Hord, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 805S - 805S
  • [35] Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia
    Leszek, Przemyslaw
    Kruszewski, Marcin
    EUROPEAN HEART JOURNAL, 2008, 29 (04) : 565 - 566
  • [36] Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia
    van Veldhuisen, Dirk J.
    Dickstein, Kenneth
    Cohen-Solal, Alain
    Lok, Dirk J. A.
    Wasserman, Scott M.
    Baker, Nigel
    Rosser, Dylan
    Cleland, John G. F.
    Ponikowski, Piotr
    EUROPEAN HEART JOURNAL, 2007, 28 (18) : 2208 - 2216
  • [37] Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
    Littlewood, TJ
    Bajetta, E
    Nortier, JWR
    Vercammen, E
    Rapoport, B
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) : 2865 - 2874
  • [38] Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy
    Kosaka, Yoshimasa
    Rai, Yoshiaki
    Masuda, Norikazu
    Takano, Toshimi
    Saeki, Toshiaki
    Nakamura, Seigo
    Shimazaki, Ryutaro
    Ito, Yoshinori
    Tokuda, Yutaka
    Tamura, Kazuo
    SUPPORTIVE CARE IN CANCER, 2015, 23 (04) : 1137 - 1143
  • [39] Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy
    Yoshimasa Kosaka
    Yoshiaki Rai
    Norikazu Masuda
    Toshimi Takano
    Toshiaki Saeki
    Seigo Nakamura
    Ryutaro Shimazaki
    Yoshinori Ito
    Yutaka Tokuda
    Kazuo Tamura
    Supportive Care in Cancer, 2015, 23 : 1137 - 1143
  • [40] Efficacy and quality of life outcomes of epoetin-α in a double-blind, placebo-controlled, multicentre study of cancer patients receiving non-platinum-containing chemotherapy
    Littlewood, TJ
    NORMAL TISSUE REACTIONS IN RADIOTHERAPY AND ONCOLOGY, 2002, 37 : 34 - 37
12345